Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.
<h4>Background</h4>Mutations in the progranulin (PGRN) gene, leading to haploinsufficiency, cause familial frontotemporal lobar degeneration (FTLD-TDP), although the pathogenic mechanism of PGRN deficit is largely unknown. Allelic loss of PGRN was previously shown to increase the activit...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8cfb0f14389d4adf9d517184e2e3f24f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8cfb0f14389d4adf9d517184e2e3f24f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8cfb0f14389d4adf9d517184e2e3f24f2021-11-18T07:18:12ZInactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.1932-620310.1371/journal.pone.0037057https://doaj.org/article/8cfb0f14389d4adf9d517184e2e3f24f2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22623979/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Mutations in the progranulin (PGRN) gene, leading to haploinsufficiency, cause familial frontotemporal lobar degeneration (FTLD-TDP), although the pathogenic mechanism of PGRN deficit is largely unknown. Allelic loss of PGRN was previously shown to increase the activity of cyclin-dependent kinase (CDK) CDK6/pRb pathway in lymphoblasts expressing the c.709-1G>A PGRN mutation. Since members of the CDK family appear to play a role in neurodegenerative disorders and in apoptotic death of neurons subjected to various insults, we investigated the role of CDK6/pRb in cell survival/death mechanisms following serum deprivation.<h4>Methodology/principal findings</h4>We performed a comparative study of cell viability after serum withdrawal of established lymphoblastoid cell lines from control and carriers of c.709-1G>A PGRN mutation, asymptomatic and FTLD-TDP diagnosed individuals. Our results suggest that the CDK6/pRb pathway is enhanced in the c.709-1G>A bearing lymphoblasts. Apparently, this feature allows PGRN-deficient cells to escape from serum withdrawal-induced apoptosis by decreasing the activity of executive caspases and lowering the dissipation of mitochondrial membrane potential and the release of cytochrome c from the mitochondria. Inhibitors of CDK6 expression levels like sodium butyrate or the CDK6 activity such as PD332991 were able to restore the vulnerability of lymphoblasts from FTLD-TDP patients to trophic factor withdrawal.<h4>Conclusion/significance</h4>The use of PGRN-deficient lymphoblasts from FTLD-TDP patients may be a useful model to investigate cell biochemical aspects of this disease. It is suggested that CDK6 could be potentially a therapeutic target for the treatment of the FTLD-TDP.Carolina AlquezarNoemí EsterasAinhoa AlzualdeFermín MorenoMatilde S AyusoAdolfo López de MunainÁngeles Martín-RequeroPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 5, p e37057 (2012) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Carolina Alquezar Noemí Esteras Ainhoa Alzualde Fermín Moreno Matilde S Ayuso Adolfo López de Munain Ángeles Martín-Requero Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A. |
description |
<h4>Background</h4>Mutations in the progranulin (PGRN) gene, leading to haploinsufficiency, cause familial frontotemporal lobar degeneration (FTLD-TDP), although the pathogenic mechanism of PGRN deficit is largely unknown. Allelic loss of PGRN was previously shown to increase the activity of cyclin-dependent kinase (CDK) CDK6/pRb pathway in lymphoblasts expressing the c.709-1G>A PGRN mutation. Since members of the CDK family appear to play a role in neurodegenerative disorders and in apoptotic death of neurons subjected to various insults, we investigated the role of CDK6/pRb in cell survival/death mechanisms following serum deprivation.<h4>Methodology/principal findings</h4>We performed a comparative study of cell viability after serum withdrawal of established lymphoblastoid cell lines from control and carriers of c.709-1G>A PGRN mutation, asymptomatic and FTLD-TDP diagnosed individuals. Our results suggest that the CDK6/pRb pathway is enhanced in the c.709-1G>A bearing lymphoblasts. Apparently, this feature allows PGRN-deficient cells to escape from serum withdrawal-induced apoptosis by decreasing the activity of executive caspases and lowering the dissipation of mitochondrial membrane potential and the release of cytochrome c from the mitochondria. Inhibitors of CDK6 expression levels like sodium butyrate or the CDK6 activity such as PD332991 were able to restore the vulnerability of lymphoblasts from FTLD-TDP patients to trophic factor withdrawal.<h4>Conclusion/significance</h4>The use of PGRN-deficient lymphoblasts from FTLD-TDP patients may be a useful model to investigate cell biochemical aspects of this disease. It is suggested that CDK6 could be potentially a therapeutic target for the treatment of the FTLD-TDP. |
format |
article |
author |
Carolina Alquezar Noemí Esteras Ainhoa Alzualde Fermín Moreno Matilde S Ayuso Adolfo López de Munain Ángeles Martín-Requero |
author_facet |
Carolina Alquezar Noemí Esteras Ainhoa Alzualde Fermín Moreno Matilde S Ayuso Adolfo López de Munain Ángeles Martín-Requero |
author_sort |
Carolina Alquezar |
title |
Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A. |
title_short |
Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A. |
title_full |
Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A. |
title_fullStr |
Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A. |
title_full_unstemmed |
Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A. |
title_sort |
inactivation of cdk/prb pathway normalizes survival pattern of lymphoblasts expressing the ftld-progranulin mutation c.709-1g>a. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2012 |
url |
https://doaj.org/article/8cfb0f14389d4adf9d517184e2e3f24f |
work_keys_str_mv |
AT carolinaalquezar inactivationofcdkprbpathwaynormalizessurvivalpatternoflymphoblastsexpressingtheftldprogranulinmutationc7091ga AT noemiesteras inactivationofcdkprbpathwaynormalizessurvivalpatternoflymphoblastsexpressingtheftldprogranulinmutationc7091ga AT ainhoaalzualde inactivationofcdkprbpathwaynormalizessurvivalpatternoflymphoblastsexpressingtheftldprogranulinmutationc7091ga AT ferminmoreno inactivationofcdkprbpathwaynormalizessurvivalpatternoflymphoblastsexpressingtheftldprogranulinmutationc7091ga AT matildesayuso inactivationofcdkprbpathwaynormalizessurvivalpatternoflymphoblastsexpressingtheftldprogranulinmutationc7091ga AT adolfolopezdemunain inactivationofcdkprbpathwaynormalizessurvivalpatternoflymphoblastsexpressingtheftldprogranulinmutationc7091ga AT angelesmartinrequero inactivationofcdkprbpathwaynormalizessurvivalpatternoflymphoblastsexpressingtheftldprogranulinmutationc7091ga |
_version_ |
1718423678046175232 |